article thumbnail

Tarsus Pharmaceuticals replaces CFO

CFO Dive

The biopharmaceutical company is parting ways with former CFO Leo Greenstein, who started at his post back in 2020.

article thumbnail

New CVS drug pricing formula won’t drive up costs, CFO says

CFO Dive

Tying the prices it charges for medicines to those charged by pharmaceutical companies will put the healthcare giant’s pharmacy business on a more sustainable footing, executives said.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CFO Corner With SCHOTT Pharma’s Almuth Steinkühler

Global Finance

Almuth Steinkhler has been CFO of SCHOTT Pharma, which designs drug containment products and drug delivery systems for pharmaceutical and biotech companies, since August 2022. However, for a CFO, the real deal starts at day one after the listing day. Steinkhler previously worked at ThyssenKrupp and Continental AG.

CFO 52
article thumbnail

1057: Building Strategic Value: Inside the Finance Engine Room | Georgy Egorov, CFO, ZeroAvia

CFO Thought Leader

Maybe it was a little bit of beginners luck, Georgy Egorov tells us, reflecting on his first CFO appointment at a biotech startup. Today, Egorovs CFO mindset is firmly anchored in building strategic value. ” Georgy Egorov, CFO, ZeroAvia CFOTL: Tell us about this companywhat does it do, and what are its offerings today?

CFO 52
article thumbnail

Entod Pharmaceuticals appoints Balasubramanian K Pillai as ​​its new CFO

CFO News

ENTOD Pharmaceuticals has appointed Balasubramanian K Pillai as its new CFO. Pillai, a Chartered Accountant with over 26 years of diverse experience, aims to enhance financial strategies and drive sustainable growth.

article thumbnail

Ep 1: Raising Capital, Resource Allocation & Book Tips

CFO Thought Leader

On this episode of 1-2-3 , Emma Seymour , CFO at Deputy, reveals the behind-the-scenes steps to raising capital from strategic partners and achieving unicorn status. Next, Dev Ahuja , CFO of Novelis , explains how his pharmaceutical background at Novartis fueled disciplined resource allocation and strategic growth in manufacturing.

article thumbnail

Pharma CFO Anthony Doyle Plans for Uncertainty

CFO

“If we tell you something, it’s because we believe it, and we’re neither sandbaggers nor are we going to lead with our chin and put out outrageous goals,” said Anthony Doyle, CFO of BioCryst Pharmaceuticals, when asked to describe how the publicly held biotech has established credibility by executing on projections.

CFO 65